Cargando…
Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells
Endothelial cells (EC) are involved in regulating several aspects of lipid metabolism, with recent research revealing the clinicopathological significance of interactions between EC and lipids. Induced pluripotent stem cells (iPSC) have various possible medical uses, so understanding the metabolism...
Autores principales: | Nakamura, Yusuke, Shimizu, Yasuo, Horibata, Yasuhiro, Tei, Rinna, Koike, Ryosuke, Masawa, Meitetsu, Watanabe, Taiji, Shiobara, Taichi, Arai, Ryo, Chibana, Kazuyuki, Takemasa, Akihiro, Sugimoto, Hiroyuki, Ishii, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571164/ https://www.ncbi.nlm.nih.gov/pubmed/28839272 http://dx.doi.org/10.1038/s41598-017-09980-x |
Ejemplares similares
-
Comparison of inducible nitric oxide synthase
mRNA expression in different airway portions and association with nitric oxide parameters from patients with asthma
por: Sato, Yoko, et al.
Publicado: (2019) -
Expression of intelectin-1 in bronchial epithelial cells of asthma is correlated with T-helper 2 (Type-2) related parameters and its function
por: Watanabe, Taiji, et al.
Publicado: (2017) -
Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells
por: Shiobara, Taichi, et al.
Publicado: (2016) -
Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)
por: Shimizu, Yasuo, et al.
Publicado: (2020) -
Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma
por: Kushima, Yoshitomo, et al.
Publicado: (2023)